Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5951
Trio-Tech International Common Stock
TRT
$57.8M
| $14K | ﹤0.01% |
5,202
+3,004
| +137% | +$6.93K |
2017 Q2
1 quarter
|
|
5952
WidePoint Corp
WYY
$69.4M
| $14K | ﹤0.01% |
2,186
| – | – |
2013 Q2
17 quarters
|
|
|
CBMG
5953
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $14K | ﹤0.01% |
1,300
-4,997
| -79% | -$47.3K |
2014 Q3
12 quarters
|
|
|
UCI
5954
DELISTED
E-TRACS UBS Bloomberg CMCI ETN
UCI
| $14K | ﹤0.01% |
988
| – | – |
2016 Q3
4 quarters
|
|
|
SAUC
5955
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $14K | ﹤0.01% |
6,737
-119,558
| -95% | -$271K |
2013 Q4
15 quarters
|
|
|
HFBC
5956
DELISTED
HopFed Bancorp Inc
HFBC
| $14K | ﹤0.01% |
950
-1,200
| -56% | -$17.1K |
2013 Q4
15 quarters
|
|
|
GYEN
5957
DELISTED
AdvisorShares Gartman Gold/Yen ETF
GYEN
| $14K | ﹤0.01% |
1,200
| – | – |
2016 Q1
6 quarters
|
|
5958
Champions Oncology
CSBR
$68.2M
| $13K | ﹤0.01% |
3,500
| – | – |
2017 Q1
2 quarters
|
|
5959
Veru
VERU
$40.9M
| $13K | ﹤0.01% |
500
+400
| +400% | +$5.85K |
2017 Q2
1 quarter
|
|
5960
DELISTED
Golden Minerals Company
AUMN
| $13K | ﹤0.01% |
+1,108
| New | +$14.8K |
2017 Q1
2 quarters
|
|
|
FGH
5961
DELISTED
FG Group Holdings Inc.
FGH
| $13K | ﹤0.01% |
2,056
| – | – |
2013 Q2
17 quarters
|
|
|
SECO
5962
DELISTED
Secoo Holding Limited ADR
SECO
| $13K | ﹤0.01% |
+150
| New | +$14.5K |
2017 Q3
0 quarters
|
|
|
FKO
5963
DELISTED
First Trust South Korea AlphaDEX Fund
FKO
| $13K | ﹤0.01% |
500
-1,746
| -78% | -$47.3K |
2013 Q4
15 quarters
|
|
|
LDF
5964
DELISTED
Latin American Discovery Fund
LDF
| $13K | ﹤0.01% |
1,014
+466
| +85% | +$5.38K |
2013 Q4
15 quarters
|
|
|
MVO
5965
DELISTED
MV Oil Trust
MVO
| $12K | ﹤0.01% |
2,000
| – | – |
2013 Q4
15 quarters
|
|
5966
Research Frontiers
REFR
$19.6M
| $12K | ﹤0.01% |
10,299
-599
| -5% | -$718 |
2013 Q4
15 quarters
|
|
5967
iShares MSCI Global Sustainable Development Goals ETF
SDG
$162M
| $12K | ﹤0.01% |
+200
| New | +$11.2K |
2017 Q3
0 quarters
|
|
5968
SELLAS Life Sciences
SLS
$2.41B
| $12K | ﹤0.01% |
22
-32
| -59% | -$21.1K |
2016 Q4
3 quarters
|
|
5969
ProShares UltraPro Short QQQ
SQQQ
$2.12B
| – | – |
-1
| Closed | -$71K | – |
|
5970
Tandy Leather Factory
TLF
$20M
| $12K | ﹤0.01% |
1,600
+188
| +13% | +$1.58K |
2016 Q4
3 quarters
|
|
|
BIOC
5971
DELISTED
Biocept, Inc.
BIOC
| $12K | ﹤0.01% |
1
| – | – |
2016 Q1
6 quarters
|
|
|
GGO
5972
DELISTED
The Gabelli Go Anywhere Trust
GGO
| $12K | ﹤0.01% |
+708
| New | +$12.1K |
2017 Q3
0 quarters
|
|
|
FNJN
5973
DELISTED
Finjan Holdings, Inc.
FNJN
| $12K | ﹤0.01% |
5,375
+3,280
| +157% | +$8.97K |
2017 Q2
1 quarter
|
|
|
OTIV
5974
DELISTED
OTI On Track Innovations Ltd
OTIV
| $12K | ﹤0.01% |
8,500
| – | – |
2013 Q4
15 quarters
|
|
5975
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $12K | ﹤0.01% |
+600
| New | +$13K |
2017 Q3
0 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.